Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorThe University of Texas Health Science Center, Houston

About this trial

The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.

Eligibility criteria

Qualifiers

Singleton pregnancy

Gestational age at screening is 19 to 25 5/7 weeks and gestational age at surgery is 22 to 25 6/7 weeks

Maternal age: 18 years and older

Body mass index ≤45 kg/m2 (pre-pregnancy)

Disqualifiers

Non-resident of the United States

Multifetal pregnancy

Poorly controlled insulin-dependent pregestational diabetes

Poorly controlled A2 diabetes mellitus (A2DM) insulin-dependent diabetes

Trial design

Treatments tested in this trial

  • NEOX Cord 1K applied fetoscopically

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

1
The University of Texas Health Science Center at Houston77030, HoustonTexas, United States

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator